Rilonacept

Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.

Map view:

Zoom: 100%

More settings

Connection length 100% Label size 100% Node size 100% Line width 100% Label width 100%

Export map as:

Rilonacept topic overview

The analysis highlights Overview, Related Topics and Entities as prominent areas in the source structure around Rilonacept.

Related topics: 12
Source areas: 1
Connected nodes: 13
Extracted relationships: 19
Related term clusters: 13
Bridge connections: 13

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

Overview · 12 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

AHFS/Drugs.com: Monograph
ATC code: L04AC04 (WHO)
CAS Number: 501081-76-1 Y
ChEMBL: ChEMBL1201830 N
ChemSpider: none
DrugBank: DB06372 Y

Start with your topic. Discover where to go next.

Explore different angles and find fresh ideas to shape your next piece of content.

Rilonacept

7Medication · Cryopyrin-associated periodic syndrome · Familial cold autoinflammatory syndrome

5Fusion protein · Fc region · Orphan drug

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

For the semantics nerds

You can skip this section if you’re here for content ideas and keyword inspiration.

Advanced semantic analysis

How Rilonacept connects Entity context

The extracted context around Rilonacept shows recurring relationship patterns in the source. For example, Rilonacept → EU: Rx-only, US: ℞-only Another extracted example is Rilonacept → EU EMA: by INN, US DailyMed: Rilonacept. Use these groups to spot repeated connection types before inspecting the individual relationships.

Top relations

Legal status · 2

Rilonacept → EU: Rx-only, US: ℞-only

License data · 2

Rilonacept → EU EMA: by INN, US DailyMed: Rilonacept

is a · 2

Rilonacept → first drug approved by the FDA to treat recurrent pericarditis, interleukin 1 inhibitor.Rilonacept is a dimeric fusion protein consisting of the ligand-binding domains of the extracellular portions of the human interleukin-1 receptor component

AHFS/Drugs.com · 1

Rilonacept → Monograph

ATC code · 1

Rilonacept → L04AC04 (WHO)

CAS Number · 1

Rilonacept → 501081-76-1 Y

ChEMBL · 1

Rilonacept → ChEMBL1201830 N

ChemSpider · 1

Rilonacept → none

DrugBank · 1

Rilonacept → DB06372 Y

Formula · 1

Rilonacept → C9030H13932N2400O2670S74

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

drug fda pericarditis used treat cryopyrin-associated periodic syndromes including familial cold autoinflammatory syndrome muckle wells interleukin-1 receptor recurrent treatment approved

Rilonacept relationships Subject–Predicate–Object triples

TTTA extracted 19 structured relationships around Rilonacept. Examples in this analysis include Rilonacept → AHFS/Drugs.com → Monograph and Rilonacept → ATC code → L04AC04 (WHO). The table shows each extracted connection, where it came from and its confidence.

Subject	Predicate	Object	Confidence	Src
Rilonacept	AHFS/Drugs.com	Monograph	1.00	infobox
Rilonacept	ATC code	L04AC04 (WHO)	1.00	infobox
Rilonacept	CAS Number	501081-76-1 Y	1.00	infobox
Rilonacept	ChEMBL	ChEMBL1201830 N	1.00	infobox
Rilonacept	ChemSpider	none	1.00	infobox
Rilonacept	DrugBank	DB06372 Y	1.00	infobox
Rilonacept	Formula	C9030H13932N2400O2670S74	1.00	infobox
Rilonacept	KEGG	D06635	1.00	infobox
Rilonacept	Legal status	US: ℞-only	1.00	infobox
Rilonacept	Legal status	EU: Rx-only	1.00	infobox
Rilonacept	License data	EU EMA: by INN	1.00	infobox
Rilonacept	License data	US DailyMed: Rilonacept	1.00	infobox
Rilonacept	Molar mass	201209.36 g·mol−1	1.00	infobox
Rilonacept	Other names	IL-1 Trap	1.00	infobox
Rilonacept	Routes of administration	Subcutaneous	1.00	infobox
Rilonacept	Trade names	Arcalyst	1.00	infobox
Rilonacept	UNII	8K80YB5GMG	1.00	infobox
Rilonacept	is a	interleukin 1 inhibitor.Rilonacept is a dimeric fusion protein consisting of the ligand-binding domains of the extracellular portions of the human interleukin-1 receptor component	0.90	text
Rilonacept	is a	first drug approved by the FDA to treat recurrent pericarditis	0.90	text

Related concept clusters Related term clusters

The concept neighborhoods around Rilonacept bring nearby vocabulary together. In this analysis, examples include Drug, Approved and Arcalyst. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

Rilonacept
- Drug
- Approved
- Arcalyst
- Il-1
- Interleukin-1
- Pericarditis
- Receptor
- Recurrent
- Treat
- Fda
- Antagonist
- Brand
rilonacept
- Drug
- Approved
- Arcalyst
- Il-1
- Interleukin-1
- Pericarditis
- Receptor
- Recurrent
- Treat
- Fda
- Antagonist
- Brand
cryopyrin-associated periodic syndromes
- Autoinflammatory
- Cold
- Familial
- Including
- Muckle
- Periodic
- Syndrome
- Syndromes
- Used
- Wells
- Antagonist
- Deficiency
familial cold autoinflammatory syndrome
- Autoinflammatory
- Cold
- Cryopyrin-associated
- Familial
- Including
- Muckle
- Periodic
- Syndrome
- Syndromes
- Used
- Wells
- Antagonist
muckle–wells syndrome
- Autoinflammatory
- Cold
- Cryopyrin-associated
- Familial
- Including
- Muckle
- Periodic
- Syndrome
- Syndromes
- Used
- Wells
- Antagonist
interleukin-1 receptor antagonist
- Brand
- Deficiency
- Medication
- Name
- Receptor
- Sold
- Antagonist
- Arcalyst
- Consisting
- Dimeric
- Domains
- Extracellular
food and drug administration
- Fda
- Treatment
- Arcalyst
- Autoinflammatory
- Cold
- Cryopyrin-associated
- Familial
- Il-1
- Including
- Muckle
- Periodic
- Syndrome
medication
- Antagonist
- Deficiency
- Name
- Sold
- Autoinflammatory
- Cold
- Cryopyrin-associated
- Familial
- Including
- Interleukin-1
- Muckle
- Pericarditis

Connections between topic areas Semantic bridges

Bridges highlight paths between different parts of the Rilonacept map and can reveal research angles that are easy to miss in a flat list.

Min side: 3

Map overview Semantic statistics

Rilonacept

Nodes14

Edges13

Triples19

Avg. degree1.86

Density0.142857

Components1

Source & methodology

TTTA analyzes the structure around Rilonacept to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Overview, Related Topics & Entities, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Rilonacept · EN edition · Analysis: TopicsToTalkAbout

Rilonacept: Overview, Related Topics & Entities

Rilonacept topic overview

What this topic covers Research coverage

Key facts & relationships

Start with your topic. Discover where to go next.

Questions to explore

Explore all related topics Closing gaps

Overview

For the semantics nerds

Advanced semantic analysis

How Rilonacept connects Entity context

Rilonacept

Top relations

Important terminology

Important terminology

Rilonacept relationships Subject–Predicate–Object triples

Related concept clusters Related term clusters

Connections between topic areas Semantic bridges

Map overview Semantic statistics

Rilonacept

Source & methodology